Cargando…
Propranolol for Infantile Haemangiomas: Experience from a Tertiary Center
AIM: Infantile haemangiomas are the most common tumor of infancy. We report the use of propranolol for treatment of problematic and complicated haemangiomas. PATIENTS AND METHODS: Propranolol was given to 52 children with mean age of 18.2 months at onset of treatment. After clinical and electrocardi...
Autores principales: | Pandey, Vaibhav, Tiwari, Preeti, Gangopadhyay, Ajay N, Gupta, Dinesh K, Sharma, Shiv P, Kumar, Vijayendar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996789/ https://www.ncbi.nlm.nih.gov/pubmed/24761098 http://dx.doi.org/10.4103/0974-2077.129975 |
Ejemplares similares
-
Re: Propranolol for infantile haemangiomas: Early experience from a tertiary center
por: Pandey, Anand, et al.
Publicado: (2014) -
Ulcerated Infantile Haemangioma of Leg Successfully Treated with Propranolol
por: Thomas, Jayakar, et al.
Publicado: (2011) -
A Clinicopathological Study to Assess the Role of Intralesional Sclerotherapy Following Propranolol Treatment in Infantile Hemangioma
por: Kumar, Rakesh, et al.
Publicado: (2021) -
Author's reply
por: Pandey, Vaibhav, et al.
Publicado: (2014) -
Propranolol, infantile haemangiomas, and serendipity: new use for an old drug
por: Grech, Victor, et al.
Publicado: (2011)